Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00913185 · ClinicalTrials.gov registry record · Phase 4

Comparison Study of Topical Acne Regimens

A Phase 4 study of Acne, sponsored by MedDerm Associates.

Completed
Registry status
Phase 4
Development phase
128
Enrollment target
1
Study location

NCT00913185: Completed Phase 4 study of Acne, sponsored by MedDerm Associates.

NCT00913185 is a Phase 4 study of Acne that has completed, run by MedDerm Associates. The registered enrollment target is 128 participants, roughly in line with the 138-participant average among 26 other Acne trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00913185, a Phase 4 study of Acne, has completed, sponsored by MedDerm Associates.

COMPLETED
Registry status
Phase 4
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effectiveness of two over the counter acne products in subjects with moderate severity acne vulgaris. The two products being compared in this study are Acne Free "Severe Acne Line" manufactured by University Medical Products, and Proactiv® manufactured by Guthy-Renker.

Conditions Studied

Interventions

  • DRUG Acne Free, Proactiv

Study Locations (1)

California

  • MedDerm Associates - San Diego

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2006-12
Est. Completion 2008-02
Phase Phase 4
MedDerm Associates

2 total trials

What the finished NCT00913185 record still lists

NCT00913185 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 138-participant average among 26 other Acne trials with a reported enrollment target.

The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 1 intervention - of which Acne Free, Proactiv is the first listed.

NCT00913185 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00913185 about?

NCT00913185 is a clinical study titled "Comparison Study of Topical Acne Regimens". The purpose of this study is to compare the effectiveness of two over the counter acne products in subjects with moderate severity acne vulgaris. The two products being compared in this study are Acne Free "Severe Acne Line" manufactured by University Medical Products, and Proactiv® manufactured by ...

What is the current status of trial NCT00913185?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 128 participants. The study started on 2006-12. Estimated completion is 2008-02.

What conditions does trial NCT00913185 study?

This clinical trial studies the following conditions: Acne.

What interventions are being tested in trial NCT00913185?

The interventions under investigation include: Acne Free, Proactiv (DRUG).

Who is sponsoring clinical trial NCT00913185?

This trial is sponsored by MedDerm Associates, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00913185 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acne

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00913185's enrollment target sits among peer trials

128 7th of 26 higher than 19 of 26 other Acne trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acne trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00913185, the US trial registry maintained by the National Library of Medicine. NCT00913185 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.